Abstract
The Programmed cell Death protein-1/Ligand 1 (PD-1/L1) checkpoint is a major target in oncology. Monoclonal antibodies targeting PD-1 or PD-L1 are use......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
